[AACR] Immunodominant Antiviral T-cell Responses Outcompete Antitumor T-cell Responses to Reduce the Efficacy of Oncolytic Viroimmunotherapy |
|
This post will be closed automatically in 2026-10-29 10:38
Reward30points
|
30
Immunodominant Antiviral T-cell Responses Outcompete Antitumor T-cell Responses to Reduce the Efficacy of Oncolytic Viroimmunotherapy
30
Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia
20
Abstract P1-05-26: MammaPrint Genomic Signature, Molecular Subtype Characteristics and Outcomes of HER2-Low Early Breast Cancer (EORTC10041 / BIG 03-04 MINDACT Trial)
